|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net of allowance of $490 and $300, respectively | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Right of use asset | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Convertible note receivable | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts payable | ||||||||||||||||||||
| Accrued expense and other current liabilities | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Short-term cash advances | ||||||||||||||||||||
| Deferred payroll tax credits | ||||||||||||||||||||
| Related party payable | ||||||||||||||||||||
| Debt, current | ||||||||||||||||||||
| Operating lease liability, current | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Long-term debt, non-current | ||||||||||||||||||||
| Long-term debt, non-current | ||||||||||||||||||||
| Operating lease liability, non-current | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| Class A Ordinary Shares | ||||||||||||||||||||
| Total warrant liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Deficit | ||||||||||||||||||||
| Common stock par value $0.0001 per share, 300,000,000 authorized at June 30, 2026; 48,795,266 issued and outstanding as of June 30, 2026; 300,000,000 authorized at December 31, 2025; 48,548,772 issued and outstanding as of December 31, 2025 | ||||||||||||||||||||
| Total common stock par value $0.0001 per share, 300,000,000 authorized at June 30, 2026; 48,795,266 issued and outstanding as of June 30, 2026; 300,000,000 authorized at December 31, 2025; 48,548,772 issued and outstanding as of December 31, 2025 | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
| Common stock, shares, outstanding (in shares) | ||||||||||||||||||||
| Total common stock, shares, outstanding (in shares) | ||||||||||||||||||||
Loading...